Search Results - "Lacerna, Leo V."

Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006 by Weitzman, Richard, Sauter, Nicholas, Eriksen, Erik Fink, Tarassoff, Peter G, Lacerna, Leo V, Dias, Rosh, Altmeyer, Anne, Csermak-Renner, Katalin, McGrath, Lynne, Lantwicki, Linda, Hohneker, John A

“…Abstract In light of recent reports of osteonecrosis of the jaw (ONJ) in cancer patients whose treatment regimens include an intravenous bisphosphonate,…”
Get full text

The Effect of Zoledronic Acid on Bone Mineral Density in Patients Undergoing Androgen Deprivation Therapy by Israeli, Ron S, Rosenberg, Steven J, Saltzstein, Daniel R, Gottesman, James E, Goldstein, Howard R, Hull, Gerald W, Tran, Diep N.H, Warsi, Ghulam M, Lacerna, Leo V

“…Abstract Purpose The aim of this study was to evaluate the efficacy and safety of zoledronic acid compared with placebo in preventing bone mineral density…”
Get full text

Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer by Ryan, Christopher W, Huo, Dezheng, Demers, Laurence M, Beer, Tomasz M, Lacerna, Leo V

“…Androgen deprivation therapy in patients with prostate cancer is associated with bone loss and an increased risk of fractures. Zoledronic acid protects against…”
Get more information

Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases by Polascik, Thomas J., Given, Robert W., Metzger, Charles, Julian, Sydney R., Vestal, James C., Karlin, Gary S., Barkley, Craig S., Bilhartz, David L., McWhorter, Laura T., Lacerna, Leo V.

“…To evaluate the efficacy and safety of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases who were…”
Get full text